Other researchers reported that ebselen treatment enhanced the activities of antioxidant enzymes such as SOD, CAT, and GPx without changing the cisplatin concentrations in cisplatin-induced AKI [165,166]. This evidence concerns the gene CAT and acute kidney injury.